スマート医療インプラント市場(用途:整形外科用インプラント、心臓血管用インプラント、眼科用インプラント、歯科用インプラント、その他) - 世界の産業分析、規模、シェア、成長、動向、予測、2023-2031年Smart Medical Implants Market (Application: Orthopedic Implants, Cardiovascular Implants, Ophthalmic Implants, Dental Implants, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031 スマート医療用インプラント市場 - レポートの範囲 TMRの調査レポート「スマート医療用インプラントの世界市場」は、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だ... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリースマート医療用インプラント市場 - レポートの範囲TMRの調査レポート「スマート医療用インプラントの世界市場」は、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。2023年を基準年、2031年を予測年として、2017年から2031年までのスマート医療用インプラントの世界市場の収益を提供しています。また、2023年から2031年までのスマート医療用インプラントの世界市場の複合年間成長率(CAGR %)も掲載しています。 本レポートは広範な調査を経て作成されています。主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、スマート医療用インプラント市場を理解しました。 二次調査には、インターネット情報源、政府機関の統計データ、ウェブサイト、業界団体なども含まれる。アナリストは、世界のスマート医療インプラント市場の様々な属性を調査するために、トップダウンアプローチとボトムアップアプローチの組み合わせを採用した。 本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、同レポートは、世界のスマート医療インプラント市場における競争力学の変化に光を投げかけています。これらは、既存の市場プレーヤーだけでなく、世界のスマート医療インプラント市場への参入に関心のある企業にとっても貴重なツールとなります。 当レポートでは、世界のスマート医療インプラント市場の競争状況について掘り下げています。世界のスマート医療用インプラント市場で事業を展開する主要企業が特定され、これらの各企業が様々な属性でプロファイリングされています。会社概要、財務状況、最近の動向、SWOTは、本レポートでプロファイリングされた世界のスマート医療インプラント市場のプレーヤーの属性です。 スマート医療用インプラントの世界市場レポートが回答した主要な質問 - 予測期間中の全地域におけるスマート医療インプラントの売上高/収益は? - スマート医療用インプラントの世界市場におけるビジネスチャンスは? - 市場の主な促進要因、阻害要因、機会、脅威は何か? - 予測期間中に最も速いCAGRで拡大する地域市場はどこか? - 2031年に世界で最も高い収益を上げると予測されるセグメントは? - 予測期間中に最も高いCAGRで拡大すると予測されるセグメントは? - 世界市場で事業を展開する各企業の市場ポジションは? スマート医療インプラント市場 - 調査目的と調査アプローチ スマート医療用インプラントの世界市場に関する包括的なレポートは、概要から始まり、調査範囲と目的が続きます。本レポートでは、本調査の目的、市場で事業を展開する主要ベンダーと流通業者、製品承認のための規制シナリオについて詳しく解説しています。 本レポートは、読みやすさを考慮し、各セクションを章ごとに分割したレイアウトになっています。本レポートは、グラフや表が適切に散りばめられた網羅的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化し、読者に視覚的に訴える。また、過去と予測期間末の主要セグメントの市場シェアを比較することもできる。 本レポートでは、世界のスマート医療用インプラント市場を製品、エンドユーザー、地域の観点から分析している。各基準の主要セグメントを詳細に調査し、2031年末時点の各セグメントにおける市場シェアを掲載しています。このような貴重な洞察により、市場関係者は世界のスマート医療用インプラント市場への投資について、情報に基づいたビジネス上の意思決定を行うことができます。 目次1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Smart Medical Implants Market 4. Market Overview 4.1. Introduction 4.1.1. Segment Definition 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Smart Medical Implants Market Analysis and Forecast, 2017-2031 4.4.1. Market Revenue Projections (US$ Bn) 5. Key Insights 5.1. Technological Advancements 5.2. Regulatory Scenario by Region/Globally 5.3. Insights on IoT Adoption and Application for Smart Healthcare 5.4. Opportunities and Challenges Associated with Smart Implants 5.5. Key Industry Events (Mergers & Acquisitions, Strategic Partnerships, Collaborations, etc.) 5.6. COVID-19 Impact Analysis 6. Global Smart Medical Implants Market Analysis and Forecast, by Application 6.1. Introduction & Definition 6.2. Key Findings/Developments 6.3. Market Value Forecast, by Application, 2017-2031 6.3.1. Orthopedic Implants 6.3.1.1. Smart Joint Implants 6.3.1.2. Smart Spinal Implants 6.3.1.3. Smart Bone Plates 6.3.1.4. Smart Orthopedic Screws 6.3.1.5. Others 6.3.2. Cardiovascular Implants 6.3.2.1. Smart Pacemakers 6.3.2.2. Smart Implantable Cardioverter-Defibrillators (ICDs) 6.3.2.3. Smart Cardiovascular Stents 6.3.2.4. Smart Cardiac Monitors 6.3.3. Ophthalmic Implants 6.3.3.1. Smart Intraocular Lenses (IOLs) 6.3.3.2. Smart Retinal Implants 6.3.3.3. Smart Glaucoma Implants 6.3.4. Dental Implants 6.3.4.1. Smart Prosthetic Teeth 6.3.4.2. Smart Dental Screws 6.3.4.3. Drug-eluting Dental Implants 6.3.4.4. Others 6.3.5. Others 6.4. Market Attractiveness Analysis, by Application 7. Global Smart Medical Implants Market Analysis and Forecast, by End-user 7.1. Introduction & Definition 7.2. Key Findings/Developments 7.3. Market Value Forecast, by End-user, 2017-2031 7.3.1. Hospitals and Clinics 7.3.2. Ambulatory Surgical Centers 7.3.3. Research Institutes and Academic Centers 7.3.4. Others 7.4. Market Attractiveness Analysis, by End-user 8. Global Smart Medical Implants Market Analysis and Forecast, by Region 8.1. Key Findings 8.2. Market Value Forecast, by Region 8.2.1. North America 8.2.2. Europe 8.2.3. Asia Pacific 8.2.4. Latin America 8.2.5. Middle East & Africa 8.3. Market Attractiveness Analysis, by Region 9. North America Smart Medical Implants Market Analysis and Forecast 9.1. Introduction 9.1.1. Key Findings 9.2. Market Value Forecast, by Application, 2017-2031 9.2.1. Orthopedic Implants 9.2.1.1. Smart Joint Implants 9.2.1.2. Smart Spinal Implants 9.2.1.3. Smart Bone Plates 9.2.1.4. Smart Orthopedic Screws 9.2.1.5. Others 9.2.2. Cardiovascular Implants 9.2.2.1. Smart Pacemakers 9.2.2.2. Smart Implantable Cardioverter-Defibrillators (ICDs) 9.2.2.3. Smart Cardiovascular Stents 9.2.2.4. Smart Cardiac Monitors 9.2.3. Ophthalmic Implants 9.2.3.1. Smart Intraocular Lenses (IOLs) 9.2.3.2. Smart Retinal Implants 9.2.3.3. Smart Glaucoma Implants 9.2.4. Dental Implants 9.2.4.1. Smart Prosthetic Teeth 9.2.4.2. Smart Dental Screws 9.2.4.3. Drug-eluting Dental Implants 9.2.4.4. Others 9.2.5. Others 9.3. Market Value Forecast, by End-user, 2017-2031 9.3.1. Hospitals and Clinics 9.3.2. Ambulatory Surgical Centers 9.3.3. Research Institutes and Academic Centers 9.3.4. Others 9.4. Market Value Forecast, by Country, 2017-2031 9.4.1. U.S. 9.4.2. Canada 9.5. Market Attractiveness Analysis 9.5.1. By Application 9.5.2. By End-user 9.5.3. By Country 10. Europe Smart Medical Implants Market Analysis and Forecast 10.1. Introduction 10.1.1. Key Findings 10.2. Market Value Forecast, by Application, 2017-2031 10.2.1. Orthopedic Implants 10.2.1.1. Smart Joint Implants 10.2.1.2. Smart Spinal Implants 10.2.1.3. Smart Bone Plates 10.2.1.4. Smart Orthopedic Screws 10.2.1.5. Others 10.2.2. Cardiovascular Implants 10.2.2.1. Smart Pacemakers 10.2.2.2. Smart Implantable Cardioverter-Defibrillators (ICDs) 10.2.2.3. Smart Cardiovascular Stents 10.2.2.4. Smart Cardiac Monitors 10.2.3. Ophthalmic Implants 10.2.3.1. Smart Intraocular Lenses (IOLs) 10.2.3.2. Smart Retinal Implants 10.2.3.3. Smart Glaucoma Implants 10.2.4. Dental Implants 10.2.4.1. Smart Prosthetic Teeth 10.2.4.2. Smart Dental Screws 10.2.4.3. Drug-eluting Dental Implants 10.2.4.4. Others 10.2.5. Others 10.3. Market Value Forecast, by End-user, 2017-2031 10.3.1. Hospitals and Clinics 10.3.2. Ambulatory Surgical Centers 10.3.3. Research Institutes and Academic Centers 10.3.4. Others 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031 10.4.1. Germany 10.4.2. U.K. 10.4.3. France 10.4.4. Italy 10.4.5. Spain 10.4.6. Rest of Europe 10.5. Market Attractiveness Analysis 10.5.1. By Application 10.5.2. By End-user 10.5.3. By Country/Sub-region 11. Asia Pacific Smart Medical Implants Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.2. Market Value Forecast, by Application, 2017-2031 11.2.1. Orthopedic Implants 11.2.1.1. Smart Joint Implants 11.2.1.2. Smart Spinal Implants 11.2.1.3. Smart Bone Plates 11.2.1.4. Smart Orthopedic Screws 11.2.1.5. Others 11.2.2. Cardiovascular Implants 11.2.2.1. Smart Pacemakers 11.2.2.2. Smart Implantable Cardioverter-Defibrillators (ICDs) 11.2.2.3. Smart Cardiovascular Stents 11.2.2.4. Smart Cardiac Monitors 11.2.3. Ophthalmic Implants 11.2.3.1. Smart Intraocular Lenses (IOLs) 11.2.3.2. Smart Retinal Implants 11.2.3.3. Smart Glaucoma Implants 11.2.4. Dental Implants 11.2.4.1. Smart Prosthetic Teeth 11.2.4.2. Smart Dental Screws 11.2.4.3. Drug-eluting Dental Implants 11.2.4.4. Others 11.2.5. Others 11.3. Market Value Forecast, by End-user, 2017-2031 11.3.1. Hospitals and Clinics 11.3.2. Ambulatory Surgical Centers 11.3.3. Research Institutes and Academic Centers 11.3.4. Others 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031 11.4.1. China 11.4.2. Japan 11.4.3. India 11.4.4. Australia & New Zealand 11.4.5. Rest of Asia Pacific 11.5. Market Attractiveness Analysis 11.5.1. By Application 11.5.2. By End-user 11.5.3. By Country/Sub-region 12. Latin America Smart Medical Implants Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast, by Application, 2017-2031 12.2.1. Orthopedic Implants 12.2.1.1. Smart Joint Implants 12.2.1.2. Smart Spinal Implants 12.2.1.3. Smart Bone Plates 12.2.1.4. Smart Orthopedic Screws 12.2.1.5. Others 12.2.2. Cardiovascular Implants 12.2.2.1. Smart Pacemakers 12.2.2.2. Smart Implantable Cardioverter-Defibrillators (ICDs) 12.2.2.3. Smart Cardiovascular Stents 12.2.2.4. Smart Cardiac Monitors 12.2.3. Ophthalmic Implants 12.2.3.1. Smart Intraocular Lenses (IOLs) 12.2.3.2. Smart Retinal Implants 12.2.3.3. Smart Glaucoma Implants 12.2.4. Dental Implants 12.2.4.1. Smart Prosthetic Teeth 12.2.4.2. Smart Dental Screws 12.2.4.3. Drug-eluting Dental Implants 12.2.4.4. Others 12.2.5. Others 12.3. Market Value Forecast, by End-user, 2017-2031 12.3.1. Hospitals and Clinics 12.3.2. Ambulatory Surgical Centers 12.3.3. Research Institutes and Academic Centers 12.3.4. Others 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031 12.4.1. Brazil 12.4.2. Mexico 12.4.3. Rest of Latin America 12.5. Market Attractiveness Analysis 12.5.1. By Application 12.5.2. By End-user 12.5.3. By Country/Sub-region 13. Middle East & Africa Smart Medical Implants Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast, by Application, 2017-2031 13.2.1. Orthopedic Implants 13.2.1.1. Smart Joint Implants 13.2.1.2. Smart Spinal Implants 13.2.1.3. Smart Bone Plates 13.2.1.4. Smart Orthopedic Screws 13.2.1.5. Others 13.2.2. Cardiovascular Implants 13.2.2.1. Smart Pacemakers 13.2.2.2. Smart Implantable Cardioverter-Defibrillators (ICDs) 13.2.2.3. Smart Cardiovascular Stents 13.2.2.4. Smart Cardiac Monitors 13.2.3. Ophthalmic Implants 13.2.3.1. Smart Intraocular Lenses (IOLs) 13.2.3.2. Smart Retinal Implants 13.2.3.3. Smart Glaucoma Implants 13.2.4. Dental Implants 13.2.4.1. Smart Prosthetic Teeth 13.2.4.2. Smart Dental Screws 13.2.4.3. Drug-eluting Dental Implants 13.2.4.4. Others 13.2.5. Others 13.3. Market Value Forecast, by End-user, 2017-2031 13.3.1. Hospitals and Clinics 13.3.2. Ambulatory Surgical Centers 13.3.3. Research Institutes and Academic Centers 13.3.4. Others 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031 13.4.1. GCC Countries 13.4.2. South Africa 13.4.3. Rest of Middle East & Africa 13.5. Market Attractiveness Analysis 13.5.1. By Application 13.5.2. By End-user 13.5.3. By Country/Sub-region 14. Competition Landscape 14.1. Market Player - Competition Matrix (By Tier and Size of Companies) 14.2. Market Share Analysis, by Company (2022) 14.3. Company Profiles 14.3.1. Medtronic 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.1.2. Product Portfolio 14.3.1.3. Financial Overview 14.3.1.4. SWOT Analysis 14.3.1.5. Strategic Overview 14.3.2. Abbott Laboratories 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.2.2. Product Portfolio 14.3.2.3. Financial Overview 14.3.2.4. SWOT Analysis 14.3.2.5. Strategic Overview 14.3.3. Boston Scientific Corporation 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.3.2. Product Portfolio 14.3.3.3. Financial Overview 14.3.3.4. SWOT Analysis 14.3.3.5. Strategic Overview 14.3.4. Johnson & Johnson 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.4.2. Product Portfolio 14.3.4.3. Financial Overview 14.3.4.4. SWOT Analysis 14.3.4.5. Strategic Overview 14.3.5. Siemens Healthineers 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.5.2. Product Portfolio 14.3.5.3. Financial Overview 14.3.5.4. SWOT Analysis 14.3.5.5. Strategic Overview 14.3.6. Smith & Nephew 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.6.2. Product Portfolio 14.3.6.3. Financial Overview 14.3.6.4. SWOT Analysis 14.3.6.5. Strategic Overview 14.3.7. Stryker Corporation 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.7.2. Product Portfolio 14.3.7.3. Financial Overview 14.3.7.4. SWOT Analysis 14.3.7.5. Strategic Overview 14.3.8. Zimmer Biomet 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.8.2. Product Portfolio 14.3.8.3. Financial Overview 14.3.8.4. SWOT Analysis 14.3.8.5. Strategic Overview 14.3.9. Cochlear Limited 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.9.2. Product Portfolio 14.3.9.3. Financial Overview 14.3.9.4. SWOT Analysis 14.3.9.5. Strategic Overview 14.3.10. Dexcom 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.10.2. Product Portfolio 14.3.10.3. Financial Overview 14.3.10.4. SWOT Analysis 14.3.10.5. Strategic Overview 14.3.11. St. Jude Medical (Abbott Laboratories) 14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.11.2. Product Portfolio 14.3.11.3. Financial Overview 14.3.11.4. SWOT Analysis 14.3.11.5. Strategic Overview 14.3.12. Edwards Lifesciences 14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.12.2. Product Portfolio 14.3.12.3. Financial Overview 14.3.12.4. SWOT Analysis 14.3.12.5. Strategic Overview 14.3.13. Biotronik 14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.13.2. Product Portfolio 14.3.13.3. Financial Overview 14.3.13.4. SWOT Analysis 14.3.13.5. Strategic Overview 14.3.14. Second Sight Medical Products 14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.14.2. Product Portfolio 14.3.14.3. Financial Overview 14.3.14.4. SWOT Analysis 14.3.14.5. Strategic Overview 14.3.15. Cyberonics (LivaNova) 14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.15.2. Product Portfolio 14.3.15.3. Financial Overview 14.3.15.4. SWOT Analysis 14.3.15.5. Strategic Overview
SummarySmart Medical Implants Market – Scope of Report Table of Contents1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Smart Medical Implants Market 4. Market Overview 4.1. Introduction 4.1.1. Segment Definition 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Smart Medical Implants Market Analysis and Forecast, 2017-2031 4.4.1. Market Revenue Projections (US$ Bn) 5. Key Insights 5.1. Technological Advancements 5.2. Regulatory Scenario by Region/Globally 5.3. Insights on IoT Adoption and Application for Smart Healthcare 5.4. Opportunities and Challenges Associated with Smart Implants 5.5. Key Industry Events (Mergers & Acquisitions, Strategic Partnerships, Collaborations, etc.) 5.6. COVID-19 Impact Analysis 6. Global Smart Medical Implants Market Analysis and Forecast, by Application 6.1. Introduction & Definition 6.2. Key Findings/Developments 6.3. Market Value Forecast, by Application, 2017-2031 6.3.1. Orthopedic Implants 6.3.1.1. Smart Joint Implants 6.3.1.2. Smart Spinal Implants 6.3.1.3. Smart Bone Plates 6.3.1.4. Smart Orthopedic Screws 6.3.1.5. Others 6.3.2. Cardiovascular Implants 6.3.2.1. Smart Pacemakers 6.3.2.2. Smart Implantable Cardioverter-Defibrillators (ICDs) 6.3.2.3. Smart Cardiovascular Stents 6.3.2.4. Smart Cardiac Monitors 6.3.3. Ophthalmic Implants 6.3.3.1. Smart Intraocular Lenses (IOLs) 6.3.3.2. Smart Retinal Implants 6.3.3.3. Smart Glaucoma Implants 6.3.4. Dental Implants 6.3.4.1. Smart Prosthetic Teeth 6.3.4.2. Smart Dental Screws 6.3.4.3. Drug-eluting Dental Implants 6.3.4.4. Others 6.3.5. Others 6.4. Market Attractiveness Analysis, by Application 7. Global Smart Medical Implants Market Analysis and Forecast, by End-user 7.1. Introduction & Definition 7.2. Key Findings/Developments 7.3. Market Value Forecast, by End-user, 2017-2031 7.3.1. Hospitals and Clinics 7.3.2. Ambulatory Surgical Centers 7.3.3. Research Institutes and Academic Centers 7.3.4. Others 7.4. Market Attractiveness Analysis, by End-user 8. Global Smart Medical Implants Market Analysis and Forecast, by Region 8.1. Key Findings 8.2. Market Value Forecast, by Region 8.2.1. North America 8.2.2. Europe 8.2.3. Asia Pacific 8.2.4. Latin America 8.2.5. Middle East & Africa 8.3. Market Attractiveness Analysis, by Region 9. North America Smart Medical Implants Market Analysis and Forecast 9.1. Introduction 9.1.1. Key Findings 9.2. Market Value Forecast, by Application, 2017-2031 9.2.1. Orthopedic Implants 9.2.1.1. Smart Joint Implants 9.2.1.2. Smart Spinal Implants 9.2.1.3. Smart Bone Plates 9.2.1.4. Smart Orthopedic Screws 9.2.1.5. Others 9.2.2. Cardiovascular Implants 9.2.2.1. Smart Pacemakers 9.2.2.2. Smart Implantable Cardioverter-Defibrillators (ICDs) 9.2.2.3. Smart Cardiovascular Stents 9.2.2.4. Smart Cardiac Monitors 9.2.3. Ophthalmic Implants 9.2.3.1. Smart Intraocular Lenses (IOLs) 9.2.3.2. Smart Retinal Implants 9.2.3.3. Smart Glaucoma Implants 9.2.4. Dental Implants 9.2.4.1. Smart Prosthetic Teeth 9.2.4.2. Smart Dental Screws 9.2.4.3. Drug-eluting Dental Implants 9.2.4.4. Others 9.2.5. Others 9.3. Market Value Forecast, by End-user, 2017-2031 9.3.1. Hospitals and Clinics 9.3.2. Ambulatory Surgical Centers 9.3.3. Research Institutes and Academic Centers 9.3.4. Others 9.4. Market Value Forecast, by Country, 2017-2031 9.4.1. U.S. 9.4.2. Canada 9.5. Market Attractiveness Analysis 9.5.1. By Application 9.5.2. By End-user 9.5.3. By Country 10. Europe Smart Medical Implants Market Analysis and Forecast 10.1. Introduction 10.1.1. Key Findings 10.2. Market Value Forecast, by Application, 2017-2031 10.2.1. Orthopedic Implants 10.2.1.1. Smart Joint Implants 10.2.1.2. Smart Spinal Implants 10.2.1.3. Smart Bone Plates 10.2.1.4. Smart Orthopedic Screws 10.2.1.5. Others 10.2.2. Cardiovascular Implants 10.2.2.1. Smart Pacemakers 10.2.2.2. Smart Implantable Cardioverter-Defibrillators (ICDs) 10.2.2.3. Smart Cardiovascular Stents 10.2.2.4. Smart Cardiac Monitors 10.2.3. Ophthalmic Implants 10.2.3.1. Smart Intraocular Lenses (IOLs) 10.2.3.2. Smart Retinal Implants 10.2.3.3. Smart Glaucoma Implants 10.2.4. Dental Implants 10.2.4.1. Smart Prosthetic Teeth 10.2.4.2. Smart Dental Screws 10.2.4.3. Drug-eluting Dental Implants 10.2.4.4. Others 10.2.5. Others 10.3. Market Value Forecast, by End-user, 2017-2031 10.3.1. Hospitals and Clinics 10.3.2. Ambulatory Surgical Centers 10.3.3. Research Institutes and Academic Centers 10.3.4. Others 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031 10.4.1. Germany 10.4.2. U.K. 10.4.3. France 10.4.4. Italy 10.4.5. Spain 10.4.6. Rest of Europe 10.5. Market Attractiveness Analysis 10.5.1. By Application 10.5.2. By End-user 10.5.3. By Country/Sub-region 11. Asia Pacific Smart Medical Implants Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.2. Market Value Forecast, by Application, 2017-2031 11.2.1. Orthopedic Implants 11.2.1.1. Smart Joint Implants 11.2.1.2. Smart Spinal Implants 11.2.1.3. Smart Bone Plates 11.2.1.4. Smart Orthopedic Screws 11.2.1.5. Others 11.2.2. Cardiovascular Implants 11.2.2.1. Smart Pacemakers 11.2.2.2. Smart Implantable Cardioverter-Defibrillators (ICDs) 11.2.2.3. Smart Cardiovascular Stents 11.2.2.4. Smart Cardiac Monitors 11.2.3. Ophthalmic Implants 11.2.3.1. Smart Intraocular Lenses (IOLs) 11.2.3.2. Smart Retinal Implants 11.2.3.3. Smart Glaucoma Implants 11.2.4. Dental Implants 11.2.4.1. Smart Prosthetic Teeth 11.2.4.2. Smart Dental Screws 11.2.4.3. Drug-eluting Dental Implants 11.2.4.4. Others 11.2.5. Others 11.3. Market Value Forecast, by End-user, 2017-2031 11.3.1. Hospitals and Clinics 11.3.2. Ambulatory Surgical Centers 11.3.3. Research Institutes and Academic Centers 11.3.4. Others 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031 11.4.1. China 11.4.2. Japan 11.4.3. India 11.4.4. Australia & New Zealand 11.4.5. Rest of Asia Pacific 11.5. Market Attractiveness Analysis 11.5.1. By Application 11.5.2. By End-user 11.5.3. By Country/Sub-region 12. Latin America Smart Medical Implants Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast, by Application, 2017-2031 12.2.1. Orthopedic Implants 12.2.1.1. Smart Joint Implants 12.2.1.2. Smart Spinal Implants 12.2.1.3. Smart Bone Plates 12.2.1.4. Smart Orthopedic Screws 12.2.1.5. Others 12.2.2. Cardiovascular Implants 12.2.2.1. Smart Pacemakers 12.2.2.2. Smart Implantable Cardioverter-Defibrillators (ICDs) 12.2.2.3. Smart Cardiovascular Stents 12.2.2.4. Smart Cardiac Monitors 12.2.3. Ophthalmic Implants 12.2.3.1. Smart Intraocular Lenses (IOLs) 12.2.3.2. Smart Retinal Implants 12.2.3.3. Smart Glaucoma Implants 12.2.4. Dental Implants 12.2.4.1. Smart Prosthetic Teeth 12.2.4.2. Smart Dental Screws 12.2.4.3. Drug-eluting Dental Implants 12.2.4.4. Others 12.2.5. Others 12.3. Market Value Forecast, by End-user, 2017-2031 12.3.1. Hospitals and Clinics 12.3.2. Ambulatory Surgical Centers 12.3.3. Research Institutes and Academic Centers 12.3.4. Others 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031 12.4.1. Brazil 12.4.2. Mexico 12.4.3. Rest of Latin America 12.5. Market Attractiveness Analysis 12.5.1. By Application 12.5.2. By End-user 12.5.3. By Country/Sub-region 13. Middle East & Africa Smart Medical Implants Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast, by Application, 2017-2031 13.2.1. Orthopedic Implants 13.2.1.1. Smart Joint Implants 13.2.1.2. Smart Spinal Implants 13.2.1.3. Smart Bone Plates 13.2.1.4. Smart Orthopedic Screws 13.2.1.5. Others 13.2.2. Cardiovascular Implants 13.2.2.1. Smart Pacemakers 13.2.2.2. Smart Implantable Cardioverter-Defibrillators (ICDs) 13.2.2.3. Smart Cardiovascular Stents 13.2.2.4. Smart Cardiac Monitors 13.2.3. Ophthalmic Implants 13.2.3.1. Smart Intraocular Lenses (IOLs) 13.2.3.2. Smart Retinal Implants 13.2.3.3. Smart Glaucoma Implants 13.2.4. Dental Implants 13.2.4.1. Smart Prosthetic Teeth 13.2.4.2. Smart Dental Screws 13.2.4.3. Drug-eluting Dental Implants 13.2.4.4. Others 13.2.5. Others 13.3. Market Value Forecast, by End-user, 2017-2031 13.3.1. Hospitals and Clinics 13.3.2. Ambulatory Surgical Centers 13.3.3. Research Institutes and Academic Centers 13.3.4. Others 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031 13.4.1. GCC Countries 13.4.2. South Africa 13.4.3. Rest of Middle East & Africa 13.5. Market Attractiveness Analysis 13.5.1. By Application 13.5.2. By End-user 13.5.3. By Country/Sub-region 14. Competition Landscape 14.1. Market Player - Competition Matrix (By Tier and Size of Companies) 14.2. Market Share Analysis, by Company (2022) 14.3. Company Profiles 14.3.1. Medtronic 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.1.2. Product Portfolio 14.3.1.3. Financial Overview 14.3.1.4. SWOT Analysis 14.3.1.5. Strategic Overview 14.3.2. Abbott Laboratories 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.2.2. Product Portfolio 14.3.2.3. Financial Overview 14.3.2.4. SWOT Analysis 14.3.2.5. Strategic Overview 14.3.3. Boston Scientific Corporation 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.3.2. Product Portfolio 14.3.3.3. Financial Overview 14.3.3.4. SWOT Analysis 14.3.3.5. Strategic Overview 14.3.4. Johnson & Johnson 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.4.2. Product Portfolio 14.3.4.3. Financial Overview 14.3.4.4. SWOT Analysis 14.3.4.5. Strategic Overview 14.3.5. Siemens Healthineers 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.5.2. Product Portfolio 14.3.5.3. Financial Overview 14.3.5.4. SWOT Analysis 14.3.5.5. Strategic Overview 14.3.6. Smith & Nephew 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.6.2. Product Portfolio 14.3.6.3. Financial Overview 14.3.6.4. SWOT Analysis 14.3.6.5. Strategic Overview 14.3.7. Stryker Corporation 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.7.2. Product Portfolio 14.3.7.3. Financial Overview 14.3.7.4. SWOT Analysis 14.3.7.5. Strategic Overview 14.3.8. Zimmer Biomet 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.8.2. Product Portfolio 14.3.8.3. Financial Overview 14.3.8.4. SWOT Analysis 14.3.8.5. Strategic Overview 14.3.9. Cochlear Limited 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.9.2. Product Portfolio 14.3.9.3. Financial Overview 14.3.9.4. SWOT Analysis 14.3.9.5. Strategic Overview 14.3.10. Dexcom 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.10.2. Product Portfolio 14.3.10.3. Financial Overview 14.3.10.4. SWOT Analysis 14.3.10.5. Strategic Overview 14.3.11. St. Jude Medical (Abbott Laboratories) 14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.11.2. Product Portfolio 14.3.11.3. Financial Overview 14.3.11.4. SWOT Analysis 14.3.11.5. Strategic Overview 14.3.12. Edwards Lifesciences 14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.12.2. Product Portfolio 14.3.12.3. Financial Overview 14.3.12.4. SWOT Analysis 14.3.12.5. Strategic Overview 14.3.13. Biotronik 14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.13.2. Product Portfolio 14.3.13.3. Financial Overview 14.3.13.4. SWOT Analysis 14.3.13.5. Strategic Overview 14.3.14. Second Sight Medical Products 14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.14.2. Product Portfolio 14.3.14.3. Financial Overview 14.3.14.4. SWOT Analysis 14.3.14.5. Strategic Overview 14.3.15. Cyberonics (LivaNova) 14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.15.2. Product Portfolio 14.3.15.3. Financial Overview 14.3.15.4. SWOT Analysis 14.3.15.5. Strategic Overview
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
Transparency Market Research社の医療分野での最新刊レポート
本レポートと同じKEY WORD(analysis size)の最新刊レポート
よくあるご質問Transparency Market Research社はどのような調査会社ですか?トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |